» Articles » PMID: 38856715

Cell-autonomous Role of Leucine-rich Repeat Kinase in the Protection of Dopaminergic Neuron Survival

Overview
Journal Elife
Specialty Biology
Date 2024 Jun 10
PMID 38856715
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease (PD). However, whether LRRK2 mutations cause PD and degeneration of dopaminergic (DA) neurons via a toxic gain-of-function or a loss-of-function mechanism is unresolved and has pivotal implications for LRRK2-based PD therapies. In this study, we investigate whether and its functional homolog play a cell-intrinsic role in DA neuron survival through the development of DA neuron-specific conditional double knockout (cDKO) mice. Unlike germline DKO mice, DA neuron-restricted cDKO mice exhibit normal mortality but develop age-dependent loss of DA neurons, as shown by the progressive reduction of DA neurons in the substantia nigra pars compacta (SNpc) at the ages of 20 and 24 months. Moreover, DA neurodegeneration is accompanied with increases in apoptosis and elevated microgliosis in the SNpc as well as decreases in DA terminals in the striatum, and is preceded by impaired motor coordination. Taken together, these findings provide the unequivocal evidence for the cell-intrinsic requirement of LRRK in DA neurons and raise the possibility that LRRK2 mutations may impair its protection of DA neurons, leading to DA neurodegeneration in PD.

Citing Articles

Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson's Disease.

Ratan Y, Rajput A, Pareek A, Pareek A, Jain V, Sonia S Biomolecules. 2024; 14(1).

PMID: 38254673 PMC: 10813470. DOI: 10.3390/biom14010073.

References
1.
Greggio E, Zambrano I, Kaganovich A, Beilina A, Taymans J, Daniels V . The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation. J Biol Chem. 2008; 283(24):16906-14. PMC: 2423262. DOI: 10.1074/jbc.M708718200. View

2.
Takanashi M, Funayama M, Matsuura E, Yoshino H, Li Y, Tsuyama S . Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations. Acta Neuropathol Commun. 2018; 6(1):105. PMC: 6192197. DOI: 10.1186/s40478-018-0617-y. View

3.
Biskup S, Moore D, Rea A, Lorenz-Deperieux B, Coombes C, Dawson V . Dynamic and redundant regulation of LRRK2 and LRRK1 expression. BMC Neurosci. 2007; 8:102. PMC: 2233633. DOI: 10.1186/1471-2202-8-102. View

4.
Heilig E, Xia W, Shen J, Kelleher 3rd R . A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activity. J Biol Chem. 2010; 285(29):22350-9. PMC: 2903357. DOI: 10.1074/jbc.M110.116962. View

5.
Tong Y, Shen J . Genetic analysis of Parkinson's disease-linked leucine-rich repeat kinase 2. Biochem Soc Trans. 2012; 40(5):1042-6. PMC: 9112632. DOI: 10.1042/BST20120112. View